½ÃÀ庸°í¼­
»óÇ°ÄÚµå
1572661

´ë»çüÇÐ ½Ã¾à : ¼¼°è ½ÃÀå Á¡À¯À²°ú ¼øÀ§, Àüü ÆÇ¸Å¿Í ¼ö¿ä ¿¹Ãø(2024-2030³â)

Metabolomics Reagents - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: QYResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¼¼°èÀÇ ´ë»çüÇÐ ½Ã¾à ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 2,618¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù.

ÀÌ ½ÃÀåÀº 2024-2030³âÀÇ ¿¹Ãø ±â°£ Áß 13.22%ÀÇ CAGR·Î È®´ëÇϸç, 2030³â¿¡´Â 6,194¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

ºÏ¹ÌÀÇ ´ë»çüÇÐ ½Ã¾à ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 1,010¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÀÌ ½ÃÀåÀº 2024-2030³âÀÇ ¿¹Ãø ±â°£ Áß 13.26%ÀÇ CAGR·Î È®´ëÇϸç, 2030³â±îÁö 2,400¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ´ë»çüÇÐ ½Ã¾à ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 655¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÀÌ ½ÃÀåÀº 2024-2030³âÀÇ ¿¹Ãø ±â°£ Áß 13.97%ÀÇ CAGR·Î È®´ëÇϸç, 2030³â±îÁö 1,622¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

À¯·´ÀÇ ´ë»çüÇÐ ½Ã¾à ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 791¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÀÌ ½ÃÀåÀº 2024-2030³âÀÇ ¿¹Ãø ±â°£ Áß 12.77%ÀÇ CAGR·Î È®´ëÇϸç, 2030³â±îÁö 1,818¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

´ë»çüÇÐ ½Ã¾àÀÇ ¼¼°è ÁÖ¿ä ±â¾÷¿¡´Â Biocrates, Cambridge Isotope Laboratories, Metware Biotechnology, IROA Technologies, Beijing BGI-GBI Biotech Co., Ltd.(GBI) µîÀÌ ÀÖ½À´Ï´Ù. 2023³â, ¼¼°è ´ëÇü 5»çÀÇ ¸ÅÃâ Á¡À¯À²Àº ¾à 71.12%ÀÔ´Ï´Ù.

¼¼°èÀÇ ´ë»çüÇÐ ½Ã¾à ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀåÀÇ °³¿ä¿Í À¯Çüº°, ¿ëµµº°, Áö¿ªº° µ¿Çâ ¹× ½ÃÀå¿¡ Âü¿©ÇÏ´Â ±â¾÷ÀÇ °³¿ä µîÀ» Á¦°øÇÏ°í ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ½ÃÀå °³¿ä

  • ´ë»çüÇÐ ½Ã¾à Á¦Ç° ¼­·Ð
  • ¼¼°èÀÇ ´ë»çüÇÐ ½Ã¾à ½ÃÀå ±Ô¸ð ¿¹Ãø(2019-2030³â)
  • ´ë»çüÇÐ ½Ã¾à ½ÃÀå µ¿Çâ°ú ÃËÁø¿äÀÎ
  • ÀüÁ¦¿Í Á¦ÇÑ
  • Á¶»ç ¸ñÀû
  • ´ë»ó³â

Á¦2Àå ±â¾÷¿¡ ÀÇÇÑ °æÀï ºÐ¼®

Á¦3Àå À¯Çüº° ¼¼ºÐÈ­

  • À¯Çüº° ¼­·Ð
  • ¼¼°èÀÇ ´ë»çüÇÐ ½Ã¾à ÆǸž×(À¯Çüº°)

Á¦4Àå ¿ëµµº° ¼¼ºÐÈ­

  • ¿ëµµº° ¼­·Ð
  • ¼¼°èÀÇ ´ë»çüÇÐ ½Ã¾à ÆǸž×(¿ëµµº°)

Á¦5Àå Áö¿ªº° ¼¼ºÐÈ­

  • ¼¼°èÀÇ ´ë»çüÇÐ ½Ã¾à ÆǸž×(Áö¿ªº°)
  • ºÏ¹Ì
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦6Àå ÁÖ¿ä ±¹°¡/Áö¿ªº° ¼¼ºÐÈ­

  • ÁÖ¿ä ±¹°¡/Áö¿ªÀÇ ´ë»çüÇÐ ½Ã¾à ÆǸŷ® ¼ºÀå µ¿Çâ, 2019³â ´ë 2023³â ´ë 2030³â
  • ÁÖ¿ä ±¹°¡/Áö¿ªÀÇ ´ë»çüÇÐ ½Ã¾à ÆǸŷ®, 2019-2030³â
  • ¹Ì±¹
  • À¯·´
  • Áß±¹
  • ÀϺ»
  • Çѱ¹

Á¦7Àå ±â¾÷ °³¿ä

  • Biocrates
  • Cambridge Isotope Laboratories
  • Metware Biotechnology
  • IROA Technologies
  • Beijing BGI-GBI Biotech Co., Ltd.(GBI)
  • Fluidome
  • BIOTERE
  • Metabolomix

Á¦8Àå »ê¾÷ üÀÎ ºÐ¼®

Á¦9Àå Á¶»ç °á°ú¿Í °á·Ð

Á¦10Àå ºÎ·Ï

KSA 24.10.25

The global market for Metabolomics Reagents was estimated to be worth US$ 26.18 million in 2023 and is forecast to a readjusted size of US$ 61.94 million by 2030 with a CAGR of 13.22% during the forecast period 2024-2030.

North American market for Metabolomics Reagents was valued at $ 10.10 million in 2023 and will reach $ 24.00 million by 2030, at a CAGR of 13.26% during the forecast period of 2024 through 2030.

Asia-Pacific market for Metabolomics Reagents was valued at $ 6.55 million in 2023 and will reach $ 16.22 million by 2030, at a CAGR of 13.97% during the forecast period of 2024 through 2030.

Europe market for Metabolomics Reagents was valued at $ 7.91 million in 2023 and will reach $ 18.18 million by 2030, at a CAGR of 12.77% during the forecast period of 2024 through 2030.

The global key companies of Metabolomics Reagents include Biocrates, Cambridge Isotope Laboratories, Metware Biotechnology, IROA Technologies and Beijing BGI-GBI Biotech Co., Ltd. (GBI) etc. In 2023, the global five largest players hold a share approximately 71.12% in terms of revenue.

This report aims to provide a comprehensive presentation of the global market for Metabolomics Reagents, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Metabolomics Reagents by region & country, by Type, and by Application.

The Metabolomics Reagents market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metabolomics Reagents.

Market Segmentation

By Company

  • Biocrates
  • Cambridge Isotope Laboratories
  • Metware Biotechnology
  • IROA Technologies
  • Beijing BGI-GBI Biotech Co., Ltd. (GBI)
  • Fluidome
  • BIOTERE
  • Metabolomix

Segment by Type

  • Targeted Metabolomics
  • Untargeted Metabolomics

Segment by Application

  • Biological Companies
  • Research Institutions
  • Educational Institutions

By Region

  • North America
  • United States
  • Canada
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Rest of Europe
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Metabolomics Reagents company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Revenue of Metabolomics Reagents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Revenue of Metabolomics Reagents in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

  • 1.1 Metabolomics Reagents Product Introduction
  • 1.2 Global Metabolomics Reagents Market Size Forecast (2019-2030)
  • 1.3 Metabolomics Reagents Market Trends & Drivers
    • 1.3.1 Metabolomics Reagents Industry Trends
    • 1.3.2 Metabolomics Reagents Market Drivers & Opportunity
    • 1.3.3 Metabolomics Reagents Market Challenges
    • 1.3.4 Metabolomics Reagents Market Restraints
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Competitive Analysis by Company

  • 2.1 Global Metabolomics Reagents Players Revenue Ranking (2023)
  • 2.2 Global Metabolomics Reagents Revenue by Company (2019-2024)
  • 2.3 Key Companies Metabolomics Reagents Manufacturing Base Distribution and Headquarters
  • 2.4 Key Companies Metabolomics Reagents Product Offered
  • 2.5 Key Companies Time to Begin Mass Production of Metabolomics Reagents
  • 2.6 Metabolomics Reagents Market Competitive Analysis
    • 2.6.1 Metabolomics Reagents Market Concentration Rate (2019-2024)
    • 2.6.2 Global 3 and 5 Largest Companies by Metabolomics Reagents Revenue in 2023
    • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metabolomics Reagents as of 2023)

3 Segmentation by Type

  • 3.1 Introduction by Type
    • 3.1.1 Targeted Metabolomics
    • 3.1.2 Untargeted Metabolomics
  • 3.2 Global Metabolomics Reagents Sales Value by Type
    • 3.2.1 Global Metabolomics Reagents Sales Value by Type (2019 VS 2023 VS 2030)
    • 3.2.2 Global Metabolomics Reagents Sales Value, by Type (2019-2030)
    • 3.2.3 Global Metabolomics Reagents Sales Value, by Type (%) (2019-2030)

4 Segmentation by Application

  • 4.1 Introduction by Application
    • 4.1.1 Biological Companies
    • 4.1.2 Research Institutions
    • 4.1.3 Educational Institutions
  • 4.2 Global Metabolomics Reagents Sales Value by Application
    • 4.2.1 Global Metabolomics Reagents Sales Value by Application (2019 VS 2023 VS 2030)
    • 4.2.2 Global Metabolomics Reagents Sales Value, by Application (2019-2030)
    • 4.2.3 Global Metabolomics Reagents Sales Value, by Application (%) (2019-2030)

5 Segmentation by Region

  • 5.1 Global Metabolomics Reagents Sales Value by Region
    • 5.1.1 Global Metabolomics Reagents Sales Value by Region: 2019 VS 2023 VS 2030
    • 5.1.2 Global Metabolomics Reagents Sales Value by Region (2019-2024)
    • 5.1.3 Global Metabolomics Reagents Sales Value by Region (2025-2030)
    • 5.1.4 Global Metabolomics Reagents Sales Value by Region (%), (2019-2030)
  • 5.2 North America
    • 5.2.1 North America Metabolomics Reagents Sales Value, 2019-2030
    • 5.2.2 North America Metabolomics Reagents Sales Value by Country (%), 2023 VS 2030
  • 5.3 Europe
    • 5.3.1 Europe Metabolomics Reagents Sales Value, 2019-2030
    • 5.3.2 Europe Metabolomics Reagents Sales Value by Country (%), 2023 VS 2030
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Metabolomics Reagents Sales Value, 2019-2030
    • 5.4.2 Asia Pacific Metabolomics Reagents Sales Value by Region (%), 2023 VS 2030
  • 5.5 Latin America
    • 5.5.1 Latin America Metabolomics Reagents Sales Value, 2019-2030
    • 5.5.2 Latin America Metabolomics Reagents Sales Value by Country (%), 2023 VS 2030
  • 5.6 Middle East & Africa

6 Segmentation by Key Countries/Regions

  • 6.1 Key Countries/Regions Metabolomics Reagents Sales Value Growth Trends, 2019 VS 2023 VS 2030
  • 6.2 Key Countries/Regions Metabolomics Reagents Sales Value, 2019-2030
  • 6.3 United States
    • 6.3.1 United States Metabolomics Reagents Sales Value, 2019-2030
    • 6.3.2 United States Metabolomics Reagents Sales Value by Type (%), 2023 VS 2030
    • 6.3.3 United States Metabolomics Reagents Sales Value by Application, 2023 VS 2030
  • 6.4 Europe
    • 6.4.1 Europe Metabolomics Reagents Sales Value, 2019-2030
    • 6.4.2 Europe Metabolomics Reagents Sales Value by Type (%), 2023 VS 2030
    • 6.4.3 Europe Metabolomics Reagents Sales Value by Application, 2023 VS 2030
  • 6.5 China
    • 6.5.1 China Metabolomics Reagents Sales Value, 2019-2030
    • 6.5.2 China Metabolomics Reagents Sales Value by Type (%), 2023 VS 2030
    • 6.5.3 China Metabolomics Reagents Sales Value by Application, 2023 VS 2030
  • 6.6 Japan
    • 6.6.1 Japan Metabolomics Reagents Sales Value, 2019-2030
    • 6.6.2 Japan Metabolomics Reagents Sales Value by Type (%), 2023 VS 2030
    • 6.6.3 Japan Metabolomics Reagents Sales Value by Application, 2023 VS 2030
  • 6.7 South Korea
    • 6.7.1 South Korea Metabolomics Reagents Sales Value, 2019-2030
    • 6.7.2 South Korea Metabolomics Reagents Sales Value by Type (%), 2023 VS 2030
    • 6.7.3 South Korea Metabolomics Reagents Sales Value by Application, 2023 VS 2030

7 Company Profiles

  • 7.1 Biocrates
    • 7.1.1 Biocrates Profile
    • 7.1.2 Biocrates Main Business
    • 7.1.3 Biocrates Metabolomics Reagents Products, Services and Solutions
    • 7.1.4 Biocrates Metabolomics Reagents Revenue (US$ Million) & (2019-2024)
  • 7.2 Cambridge Isotope Laboratories
    • 7.2.1 Cambridge Isotope Laboratories Profile
    • 7.2.2 Cambridge Isotope Laboratories Main Business
    • 7.2.3 Cambridge Isotope Laboratories Metabolomics Reagents Products, Services and Solutions
    • 7.2.4 Cambridge Isotope Laboratories Metabolomics Reagents Revenue (US$ Million) & (2019-2024)
    • 7.2.5 Cambridge Isotope Laboratories Recent Developments
  • 7.3 Metware Biotechnology
    • 7.3.1 Metware Biotechnology Profile
    • 7.3.2 Metware Biotechnology Main Business
    • 7.3.3 Metware Biotechnology Metabolomics Reagents Products, Services and Solutions
    • 7.3.4 Metware Biotechnology Metabolomics Reagents Revenue (US$ Million) & (2019-2024)
  • 7.4 IROA Technologies
    • 7.4.1 IROA Technologies Profile
    • 7.4.2 IROA Technologies Main Business
    • 7.4.3 IROA Technologies Metabolomics Reagents Products, Services and Solutions
    • 7.4.4 IROA Technologies Metabolomics Reagents Revenue (US$ Million) & (2019-2024)
  • 7.5 Beijing BGI-GBI Biotech Co., Ltd. (GBI)
    • 7.5.1 Beijing BGI-GBI Biotech Co., Ltd. (GBI) Profile
    • 7.5.2 Beijing BGI-GBI Biotech Co., Ltd. (GBI) Main Business
    • 7.5.3 Beijing BGI-GBI Biotech Co., Ltd. (GBI) Metabolomics Reagents Products, Services and Solutions
    • 7.5.4 Beijing BGI-GBI Biotech Co., Ltd. (GBI) Metabolomics Reagents Revenue (US$ Million) & (2019-2024)
  • 7.6 Fluidome
    • 7.6.1 Fluidome Profile
    • 7.6.2 Fluidome Main Business
    • 7.6.3 Fluidome Metabolomics Reagents Products, Services and Solutions
    • 7.6.4 Fluidome Metabolomics Reagents Revenue (US$ Million) & (2019-2024)
  • 7.7 BIOTERE
    • 7.7.1 BIOTERE Profile
    • 7.7.2 BIOTERE Main Business
    • 7.7.3 BIOTERE Metabolomics Reagents Products, Services and Solutions
    • 7.7.4 BIOTERE Metabolomics Reagents Revenue (US$ Million) & (2019-2024)
  • 7.8 Metabolomix
    • 7.8.1 Metabolomix Profile
    • 7.8.2 Metabolomix Main Business
    • 7.8.3 Metabolomix Metabolomics Reagents Products, Services and Solutions
    • 7.8.4 Metabolomix Metabolomics Reagents Revenue (US$ Million) & (2019-2024)

8 Industry Chain Analysis

  • 8.1 Metabolomics Reagents Industrial Chain
  • 8.2 Metabolomics Reagents Raw Materials Analysis
    • 8.2.1 Key Raw Materials
    • 8.2.2 Manufacturing Cost Structure
  • 8.3 Customers Analysis
  • 8.4 Sales Model and Sales Channels
  • 8.5 Metabolomics Reagents Distributors

9 Research Findings and Conclusion

10 Appendix

  • 10.1 Research Methodology
    • 10.1.1 Methodology/Research Approach
    • 10.1.2 Data Source
  • 10.2 Author Details
  • 10.3 Disclaimer
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óÇ°À» ¼±Åà Áß
»óÇ° ºñ±³Çϱâ
Àüü»èÁ¦